Back to results
US 12,410,137 B2Granted
Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof
AssigneeApogee Pharmaceuticals, Inc.
InventorsSafwat Mohamed Rabea, KK Durgarao Viswanadham, Gopi Kishore Valluru, Kaiji Hu
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to fatty acid amide hydrolase (FAAH) modulators, inhibitors, or FAAH modulators and inhibitors and methods and uses thereof. The FAAH modulators, inhibitors, or FAAH modulators and inhibitors may be compounds having Formula I, II, III or IV. Pharmaceutical compositions comprising the FAAH modulators, inhibitors, or FAAH modulators and inhibitors are also provided.
Claims20
A compound of Formula I:
- a prodrug thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically active metabolite thereof;
- wherein
- W is NH, N(CH3), or none, wherein when W is none R3 is directly attached to C(O) by a single bond;
- X is CH or N;
- Y is CH or N;
- Z is CH or N;
- wherein one of X, Y or Z is N;
- R1 is independently —C(O)OR4, —C(O)NHOH, —C(O)NHNH2, CF3, CHO, CN or heteroaryl;
- wherein R4 may be independently C1-C5 alkyl;
- R2 is independently hydrogen, halogen, hydroxy, alkyl, alkoxy, thioalkyl, haloalkoxy, cyano, N(CH3)2, wherein R2 may be linked via any position on the phenyl ring;
- R3 is independently C5-C20 alkyl, C3-C8 cycloalkyl, C4-C8 heterocycloalkyl, C5-12 fused heterocycloakyl, C6-12 spirocycloalkyl, or aryl, wherein R3 may be unsubstituted or substituted at a carbon ring member with halogen or alkyl group.
8 more elements
Dependencies are inferred from the claim text.